ACADIA HEALTHCARE CO INC (ACHC) Fundamental Analysis & Valuation
NASDAQ:ACHC • US00404A1097
Current stock price
27 USD
+0.11 (+0.41%)
At close:
26.68 USD
-0.32 (-1.19%)
After Hours:
This ACHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ACHC Profitability Analysis
1.1 Basic Checks
- In the past year ACHC was profitable.
- ACHC had a positive operating cash flow in the past year.
- The reported net income has been mixed in the past 5 years: ACHC reported negative net income in multiple years.
- ACHC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of ACHC (-19.95%) is worse than 78.00% of its industry peers.
- ACHC has a worse Return On Equity (-56.58%) than 72.00% of its industry peers.
- ACHC has a Return On Invested Capital of 6.00%. This is in the better half of the industry: ACHC outperforms 62.00% of its industry peers.
- ACHC had an Average Return On Invested Capital over the past 3 years of 7.42%. This is in line with the industry average of 8.51%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.95% | ||
| ROE | -56.58% | ||
| ROIC | 6% |
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
1.3 Margins
- The Operating Margin of ACHC (11.71%) is better than 84.00% of its industry peers.
- In the last couple of years the Operating Margin of ACHC has declined.
- ACHC does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.71% | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ACHC Health Analysis
2.1 Basic Checks
- ACHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- The number of shares outstanding for ACHC has been reduced compared to 1 year ago.
- ACHC has more shares outstanding than it did 5 years ago.
- The debt/assets ratio for ACHC is higher compared to a year ago.
2.2 Solvency
- ACHC has an Altman-Z score of 1.11. This is a bad value and indicates that ACHC is not financially healthy and even has some risk of bankruptcy.
- ACHC has a worse Altman-Z score (1.11) than 67.00% of its industry peers.
- A Debt/Equity ratio of 1.27 is on the high side and indicates that ACHC has dependencies on debt financing.
- ACHC has a worse Debt to Equity ratio (1.27) than 67.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.11 |
ROIC/WACC0.72
WACC8.33%
2.3 Liquidity
- A Current Ratio of 1.55 indicates that ACHC should not have too much problems paying its short term obligations.
- ACHC has a Current ratio (1.55) which is comparable to the rest of the industry.
- A Quick Ratio of 1.54 indicates that ACHC should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.54, ACHC is in the better half of the industry, outperforming 63.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.54 |
3. ACHC Growth Analysis
3.1 Past
- The earnings per share for ACHC have decreased strongly by -38.79% in the last year.
- ACHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.12% yearly.
- Looking at the last year, ACHC shows a small growth in Revenue. The Revenue has grown by 5.04% in the last year.
- Measured over the past years, ACHC shows a quite strong growth in Revenue. The Revenue has been growing by 9.65% on average per year.
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%
3.2 Future
- ACHC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.96% yearly.
- Based on estimates for the next years, ACHC will show a small growth in Revenue. The Revenue will grow by 6.26% on average per year.
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. ACHC Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 13.37 indicates a correct valuation of ACHC.
- 86.00% of the companies in the same industry are more expensive than ACHC, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of ACHC to the average of the S&P500 Index (27.87), we can say ACHC is valued rather cheaply.
- The Price/Forward Earnings ratio is 17.80, which indicates a rather expensive current valuation of ACHC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ACHC indicates a somewhat cheap valuation: ACHC is cheaper than 67.00% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 38.51. ACHC is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.37 | ||
| Fwd PE | 17.8 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACHC indicates a somewhat cheap valuation: ACHC is cheaper than 78.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 8.41 |
4.3 Compensation for Growth
- ACHC's earnings are expected to decrease with -2.66% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
5. ACHC Dividend Analysis
5.1 Amount
- ACHC does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ACHC Fundamentals: All Metrics, Ratios and Statistics
27
+0.11 (+0.41%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/bmo
Earnings (Next)04-29 2026-04-29/amc
Inst Owners133.55%
Inst Owner Change0.01%
Ins Owners0.96%
Ins Owner Change1.51%
Market Cap2.48B
Revenue(TTM)3.31B
Net Income(TTM)-1.10B
Analysts74
Price Target23.46 (-13.11%)
Short Float %24.33%
Short Ratio6.08
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.79%
Min EPS beat(2)5.25%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)12.66%
Min EPS beat(4)5.25%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)5.22%
EPS beat(12)10
Avg EPS beat(12)4.68%
EPS beat(16)13
Avg EPS beat(16)10.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)20.15%
PT rev (3m)8.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-22.25%
EPS NY rev (1m)0.94%
EPS NY rev (3m)-26.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.19%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.71%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.37 | ||
| Fwd PE | 17.8 | ||
| P/S | 0.75 | ||
| P/FCF | N/A | ||
| P/OCF | 18.84 | ||
| P/B | 1.27 | ||
| P/tB | 4.47 | ||
| EV/EBITDA | 8.41 |
EPS(TTM)2.02
EY7.48%
EPS(NY)1.52
Fwd EY5.62%
FCF(TTM)-4.78
FCFYN/A
OCF(TTM)1.43
OCFY5.31%
SpS36
BVpS21.18
TBVpS6.04
PEG (NY)N/A
PEG (5Y)N/A
Graham Number31.0244 (14.91%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.95% | ||
| ROE | -56.58% | ||
| ROCE | 7.76% | ||
| ROIC | 6% | ||
| ROICexc | 6.16% | ||
| ROICexgc | 8.63% | ||
| OM | 11.71% | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ROICexc(3y)7.58%
ROICexc(5y)7.53%
ROICexgc(3y)13.72%
ROICexgc(5y)14.49%
ROCE(3y)9.6%
ROCE(5y)9.52%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-7.02%
ROICexc growth 5Y2.87%
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.27 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 4.3 | ||
| Cap/Depr | 302.15% | ||
| Cap/Sales | 17.26% | ||
| Interest Coverage | 3.11 | ||
| Cash Conversion | 22.85% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.55 | ||
| Quick Ratio | 1.54 | ||
| Altman-Z | 1.11 |
F-Score5
WACC8.33%
ROIC/WACC0.72
Cap/Depr(3y)361.37%
Cap/Depr(5y)312.98%
Cap/Sales(3y)17.88%
Cap/Sales(5y)15.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
EPS Next Y-24.92%
EPS Next 2Y-7.57%
EPS Next 3Y-2.66%
EPS Next 5Y-1.96%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%
EBIT growth 1Y-25.72%
EBIT growth 3Y-4.55%
EBIT growth 5Y3.12%
EBIT Next Year46.21%
EBIT Next 3Y18%
EBIT Next 5Y20.08%
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.7%
OCF growth 3Y-29.76%
OCF growth 5Y-25.73%
ACADIA HEALTHCARE CO INC / ACHC Fundamental Analysis FAQ
What is the fundamental rating for ACHC stock?
ChartMill assigns a fundamental rating of 3 / 10 to ACHC.
What is the valuation status for ACHC stock?
ChartMill assigns a valuation rating of 4 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.
What is the profitability of ACHC stock?
ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 3 / 10.
What is the valuation of ACADIA HEALTHCARE CO INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ACADIA HEALTHCARE CO INC (ACHC) is 13.37 and the Price/Book (PB) ratio is 1.27.
What is the financial health of ACADIA HEALTHCARE CO INC (ACHC) stock?
The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.